Loading…
ANI Pharmaceuticals, Inc. is projected to rise to $94.86 by 2027, a +16% move from its current price of $81.76. ANIP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $80.59 | $81.79 | $83.01 | +0.04% |
| May 30 | $80.13 | $81.82 | $83.55 | +0.08% |
| May 31 | $79.78 | $81.85 | $83.98 | +0.12% |
| Jun 1 | $79.50 | $81.89 | $84.34 | +0.15% |
| Jun 2 | $79.25 | $81.92 | $84.67 | +0.19% |
| Jun 3 | $79.03 | $81.95 | $84.97 | +0.23% |
| Jun 4 | $78.84 | $81.98 | $85.25 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $78.84 | $81.98 | $85.25 | +0.27% |
| Week 2 | $77.78 | $82.20 | $86.88 | +0.54% |
| Week 3 | $77.02 | $82.42 | $88.20 | +0.81% |
| Week 4 | $76.43 | $82.65 | $89.37 | +1.08% |
| Week 5 | $75.93 | $82.87 | $90.44 | +1.36% |
| Week 6 | $75.50 | $83.09 | $91.45 | +1.63% |
| Week 7 | $75.12 | $83.32 | $92.40 | +1.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. It provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.
The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals, Inc. trades under the symbol ANIP in the Healthcare sector. The stock is currently priced at $82.72 with a market capitalization of $1.88B and holds a rank of 2047.
The near-term picture shows the price at a level consistent with a neutral posture in 2026, where the forecasted average price is $82.72. The longer-term path envisions rising averages, with 2030, 2040, and 2050 displaying notable upside in the forecast.
A major floor 13.8% below — a decisive break under it would weaken the trend.
The nearest floor, 6.5% below — buyers have tended to step in here.
The nearest ceiling, 3.5% above — a clean break opens room to run.
A major ceiling 9.0% above — clearing it would confirm fresh momentum.
Key ANIP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANIP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $82.13 | Sell | $81.68 | Buy |
| MA 10 | $80.88 | Buy | $81.33 | Buy |
| MA 20 | $81.08 | Buy | $80.80 | Buy |
| MA 50 | $78.63 | Buy | $79.64 | Buy |
| MA 100 | $78.76 | Buy | $79.58 | Buy |
| MA 200 | $83.90 | Sell | $78.74 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.38 | Neutral |
| Stoch RSI (14) | 49.01 | Neutral |
| CCI (20) | 27.26 | Neutral |
| Williams %R (14) | -36.44 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -0.12 | Sell |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 63.56 | Neutral |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | 1.87 | Buy |
| Ultimate (7,14,28) | 65.36 | Neutral |
| Momentum (10) | 2.26 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 82.78 | Sell |
| ADX (14) | 10.99 | Neutral |
| ATR (14) | 1.17 | Info |
The 30-day technical picture is described as BULLISH with an RSI(14) of 60.
Key moving averages show the price trading above the SMA50 of $78.22, while the SMA200 sits at $83.83. The 30-day range spans from $74.77 to $91.52, with a support level at $76.48 and a resistance level at $84.63.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $70.49 | $81.76 | $108.92 | 0% | Neutral | |
| $77.49 | $94.86 | $121.54 | +16% | Neutral | |
| $85.29 | $106.31 | $139.77 | +30% | Bullish | |
| $94.02 | $118.96 | $159.66 | +46% | Bullish | |
| $110.64 | $141.87 | $193.77 | +74% | Bullish | |
| $125.19 | $162.46 | $225.35 | +99% | Bullish | |
| $131.17 | $172.13 | $242.12 | +111% | Bullish | |
| $140.58 | $186.39 | $265.55 | +128% | Bullish | |
| $141.36 | $189.29 | $272.87 | +132% | Bullish | |
| $146.56 | $198.09 | $288.72 | +142% | Bullish | |
| $219.88 | $309.91 | $473.21 | +279% | Bullish | |
| $436.26 | $659.37 | $1,078.91 | +706% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $70.49 | $81.76 | $96.09 | +0.00% |
| June 2026 | $72.63 | $84.73 | $100.75 | +3.63% |
| July 2026 | $72.17 | $84.68 | $101.65 | -0.05% |
| August 2026 | $72.28 | $85.19 | $103.00 | +0.60% |
| September 2026 | $74.24 | $87.82 | $106.82 | +3.10% |
| October 2026 | $74.57 | $88.51 | $108.24 | +0.78% |
| November 2026 | $73.17 | $87.11 | $107.03 | -1.58% |
| December 2026 | $73.92 | $88.25 | $108.92 | +1.32% |
Click any year to see its month-by-month ANIP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ANIP could reach as high as $108.92, with a base case around $81.76 and support toward $70.49 — roughly 0% from $81.76. A consolidation phase looks the most probable path here.
Expect ANIP to range from $77.49 to $121.54 through 2027. The $94.86 average target implies a +16% move from current prices. That is up +16% on the projected 2026 average. Price action looks broadly range-bound.
The ANIP price prediction for 2028 points to an average of $106.31 (low $85.29, high $139.77) — a potential gain of +30% on today's $81.76. Buyers look set to stay in control over this stretch.
In 2029, ANIP is projected to trade between $94.02 and $159.66, averaging $118.96 — a potential gain of +46% from today's $81.76. That is up +12% on the projected 2028 average. Momentum favours further upside here.
ANI Pharmaceuticals, Inc.'s 2030 outlook centres on $141.87, within a $110.64 to $193.77 range. That is up +19% on the projected 2029 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ANIP could reach as high as $225.35, with a base case around $162.46 and support toward $125.19 — roughly +99% from $81.76. Momentum favours further upside here.
Expect ANIP to range from $131.17 to $242.12 through 2032. The $172.13 average target implies a +111% move from current prices. That is up +6% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ANIP price prediction for 2033 points to an average of $186.39 (low $140.58, high $265.55) — a potential gain of +128% on today's $81.76. Momentum favours further upside here.
In 2034, ANIP is projected to trade between $141.36 and $272.87, averaging $189.29 — a potential gain of +132% from today's $81.76. That is up +2% on the projected 2033 average. Buyers look set to stay in control over this stretch.
ANI Pharmaceuticals, Inc.'s 2035 outlook centres on $198.09, within a $146.56 to $288.72 range. That is up +5% on the projected 2034 average. That marks a +142% change versus current levels. Momentum favours further upside here.
By 2040, ANIP could reach as high as $473.21, with a base case around $309.91 and support toward $219.88 — roughly +279% from $81.76. Buyers look set to stay in control over this stretch.
Expect ANIP to range from $436.26 to $1,078.91 through 2050. The $659.37 average target implies a +706% move from current prices. That is up +113% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ANIP today (≈ 12.23092 ANIP) could be worth
$8,064.74
+$7,064.74 (+706%) by 2050 · US Dollar
Based on the average projected ANIP price of $659.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANIPwould be worth at today's price.
$1,000 invested in ANIP on May 27, 2025 (≈ 17.146776 ANIP) would be worth
$1,401.92
+$401.92 (+40.2%) today · 1.40× · US Dollar
Based on a ANIP entry price of $58.32 vs. today's $81.76.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $82 | $997.07 | -0.3% |
| 1 month ago | $79.6 | $1,027.14 | +2.7% |
| 3 months ago | $77.15 | $1,059.75 | +6.0% |
| 6 months ago | $84.85 | $963.58 | -3.6% |
| 1 year ago | $58.32 | $1,401.92 | +40.2% |
| All time (5.0y) ago | $35.31 | $2,315.49 | +131.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANIP forecast.
Our base-case forecast reaches $160.00 around 2031.
Implied market cap at $160.00: $3.64B
2030: min $115.81, avg $148.51, max $202.90; ROI 79.5; sentiment BULLISH.
2040: min $236.80, avg $333.81, max $509.76; ROI 303.5; sentiment BULLISH.
2050: min $479.59, avg $724.92, max $1,186.27; ROI 776.4; sentiment BULLISH.
These multi-year forecasts show a path of rising averages and substantial upside, with bullish sentiment indicated for 2030, 2040, and 2050. Note that these figures are estimates and not guaranteed.
Tap a question to reveal the answer.
2030 min $115.81; avg $148.51; max $202.90; ROI 79.5; sentiment BULLISH.
The forecast shows rising averages and bullish sentiment across the long term, with 2030 avg $148.51, 2040 avg $333.81, and 2050 avg $724.92, plus higher max values. Near term, 2026 avg is $82.72 with ROI 0 and neutral sentiment, while 2027–2029 show continued growth.
The 2030 forecast max is $202.90, indicating a potential move around the $200 level in the horizon.
Current price $82.72; Market cap $1.88B.
Sentiment BULLISH; RSI(14) 60; SMA50 $78.22; SMA200 $83.83; 30-day range $74.77-$91.52; support $76.48; resistance $84.63.
ANI Pharmaceuticals, Inc. Community Discussion
0Share your ANI Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.